Happy Sunday everyone and welcome to Money Talk Sundayz. If you’re tuning in via spotify, anchor, or from any of the popular podcast streaming platforms I’m your host Stevie Bee. Go ahead and drop a like on your way in the door. Let’s rap money.
Let’s talk about some of the winners of this past week. At the top of the list with the biggest gains for the week is Eargo, ticker symbol, EAR. Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Although this stock traded down $0.23 during trading Friday hitting $2.41 for the week, EAR is still up 111.4% We can agree that the new government ruling allowing for ear aids to be sold over the counter played a part in this stocks’ crazy jump. Considering the jump however, do you buy, sell, or hold? Generally after big gains many investors grab their profits and run causing stock prices to fall. It appears that the profit taking started early Friday so maybe about Tuesday/Wednesday would be a good time to buy if this stock interests you. If you’re already holding, I do see another rebound in the coming weeks before this stock settles.
Coming in at number 2 is Aeglea BioTherapeutics. For the week AGLE is up 75.4% with a current price of $0.91. Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency.
Current price target for this stock is $1.17 with a healthy short interest. Only 1.65% of shares are currently being sold short. Wells Fargo & Company reduced their price target on shares of Aeglea BioTherapeutics from $2.00 to $1.50. Even after rising 85% this past week AGLE shareholders are still down 88% over the past three years. There is room to grow with this one so jump in, swing, and jump out. We’re focused on short term trades while the market works out its volatility.
Rounding out the top 5 is one of our favorite meme stocks, Vinco Ventures aka BBIG. We’ve covered this stock before in our last season. If you haven’t seen or heard it, definitely check it out. BBIG is up 63% for the week closing out trading Friday at $1.45. After BBIG is Hill International or HIL. HIL is up 58% on the week closing at $2.81. Finally, there is Horizon Global or HZN. HZN is up 44.4% closing trading at $2.39.
Horizon Global Corporation engages in the design, manufacture, and distribution of towing, trailering, cargo management, and other related accessory products worldwide. It operates in two segments, Horizon Americas and Horizon Europe-Africa. The company provides towing products, such as hitches/tow bars, fifth wheels, gooseneck hitches, weight distribution systems, brake controllers, wiring harnesses, draw bars, ball mounts, crossbars, security products, and other towing accessories.
These are your top 5 stocks of the previous week ladies and gents. Are you invested in any of these stocks? If so, what is your trading strategy? Let’s chat. This is Stevie Bee and as always bros nation happy trading. See you next week.